PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Université de Paris, IAME, INSERM, Paris, France.\', \'Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.\', \'Institut Hospitalo-Universitaire Méditerranée Infection, UMR \'Emergence des Pathologies Virales\' (EPV: Aix-Marseille University - IRD 190 - Inserm 1207 - EHESP), Marseille, France.\', \'Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.\', \'Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.\', \'CIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.\', \'Certara, Integrated Drug Development, Princeton, New Jersey, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/psp4.12543
?:hasPublicationType
?:journal
  • CPT: pharmacometrics & systems pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32558354
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32558354>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32558354>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all